Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(14%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
29%
Ph early_phase_1
1
14%
Ph not_applicable
2
29%
Ph phase_4
2
29%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 4Post-market surveillance
2(28.6%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(5)
Other(1)

Detailed Status

Completed5
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (14.3%)
Phase 22 (28.6%)
Phase 42 (28.6%)
N/A2 (28.6%)

Trials by Status

completed571%
unknown114%
recruiting114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
7